期刊文献+

大鼠肠道水解酶对淫羊藿黄酮苷的处置影响 被引量:14

Influence of Rat Intestinal Hydrolase on Dispose of Flavonoids in Herb Epimedii
原文传递
导出
摘要 目的研究大鼠肠道水解酶对淫羊藿所含黄酮成分淫羊藿苷、朝藿定A、朝藿定B、朝藿定C在肠道处置的影响。方法应用大鼠在体肠灌流模型,用高效液相法测定药物浓度,比较淫羊藿黄酮苷在加入肠道乳糖酶根皮苷水解酶(LPH酶)抑制剂葡糖酸内酯(gluconolactone)前后表观渗透系数的变化。结果加入抑制剂后,4个淫羊藿黄酮苷在大鼠十二指肠、空肠、回肠、结肠的表观渗透系数都有不同程度的下降,其中淫羊藿苷在4个肠段的水解抑制率分别为:62%,50%,40%,46%;朝藿定A分别为:55%,26%,21%,14%;朝藿定B分别为:42%,40%,74%,22%;朝藿定C分别为:42%,40%,52%,35%。结论LPH酶抑制剂葡糖酸内酯能不同程度地抑制淫羊藿苷、朝藿定A、朝藿定B、朝藿定C在大鼠肠道的水解,说明大鼠肠黏膜上的LPH酶参与了淫羊藿苷、朝藿定A,B,C在肠道的代谢。 OBJECTIVE To study the influence of rat intestinal hydrotase on the d ispose of flavonoids ( icariin, epimedin A, epimedin B, epimedin C) in Herb Epimedii. METHODS Using the rat intestinal perfusion model, the contents of the four flavonoids in perfusates were measured by HPLC and the permeability coeffieients of different intestinal segments were calculated. RESULTS After adding LPH (lactasc phlorizin hydrolase) inhibitor gluconolactone, the permeabilities of 4 flavonoid compounds decreased in different intestinal segments, and their hydrolysis inhibition ratios in duodenum, jejunum, ileum, and colon according to the sequence were as follows: icariin, 62% , 50%, 40% and 46% ; epimedin A, 55% , 26% , 21% and 14% ; epimedin B, 42%, 40%, 74% and 22% ; epimedin C, 42%, 40%, 52% and 35%, respectively. CONCLUSION The inhibitior of LPH could inhibit the hydrolysis of icariin and epimedin A, B and C. The lactasc phlorizin hydrolase might involve in the dispose of the flavonoids in Herb Epimedii in intestines.
出处 《中国药学杂志》 CAS CSCD 北大核心 2010年第7期516-519,共4页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(30572372)
关键词 乳糖酶根皮苷水解酶抑制剂 大鼠肠灌流模型 淫羊藿黄酮苷 表观渗透系数 inhibitior of lactasc phlorizin hydrolase rat intestinal perfusion model flavonoids in Herb Epimedii permeability coefficient
  • 相关文献

参考文献9

  • 1WANG S W J, CHEN J, JIA X B, et al. Disposition of flavonoids via enteric recycling: Structural effects and lack of correlations between in vitro and in situ metabolic properties [ J ]. Drug Metab Dispos,2006,34 ( 11 ) : 1837-1848.
  • 2CHEN J, LIN H, HUM. Metabolism of flavonoids via enteric recycling: Role of intestinal disposition[J]. J Pharmacol Exp Ther, 2003, 304( 3 ) : 1228-1235.
  • 3SESINK A L A, ARTS I C W, FAASSEN-PETERS M, et al. Intestinal uptake of quercetin-3-glucoside in rats involves hydrolysis by Iactase phlorizin hydrolase [ J ]. J Nutr, 2003,133 ( 3 ) : 773- 776.
  • 4HUANGXL ZhOUYW WANGW.Pharmacological advancement of flavonoids in Herb Epimedii .中成药,2005,27(6):719-721.
  • 5陈彦,贾晓斌,HU Ming.Caco-2细胞单层研究淫羊藿黄酮类成分的吸收转运[J].中草药,2009,40(2):220-224. 被引量:32
  • 6叶丽卡,陈济民,刘四海,李国秀.淫羊藿苷在大鼠体内的药代动力学[J].中国药学杂志,1999,34(1):33-36. 被引量:47
  • 7LIU Z Q, JIANG Z H, LIU L, et al. Mechanisms responsible for poor oral bioavailability of paeoniflorin : Role of intestinal disposition and interactions with sinomenine [ J ]. Pharm Res,2006, 23 (12) :2768-2780.
  • 8CHEN J, LIN H M, HU M. Metabolism of flavonoid via enteric recycling : Role of intestinal disposition[ J]. Pharmacol Exp Ther, 2003, 304 ( 3 ) : 1228-1235.
  • 9LIU Y, LIU Y, DAI Y,et al. Enteric disposition an recycling of flavonoids and ginkgo flavonoids [ J ]. Alter Complement Med, 2003,9(5) :631--640.

二级参考文献22

  • 1李青南,吴铁,谢华,黄莲芳,张志平.淫羊藿提取液对去睾丸大鼠骨代谢的影响[J].中草药,1993,24(12):637-638. 被引量:87
  • 2黄秀兰,周亚伟,王伟.淫羊藿黄酮类化合物药理研究进展[J].中成药,2005,27(6):719-721. 被引量:92
  • 3李梨,周岐新,石京山.淫羊藿苷药理作用研究进展[J].中国药房,2005,16(12):952-954. 被引量:51
  • 4王天然 邢善田.淫羊藿总黄酮促进免疫功能的实验[J].中成药研究,1987,9(2):27-27.
  • 5孟娟如.大白鼠颈静脉及肝门静脉持久性插管术及其应用[J].药学学报,1987,22(5):326-326.
  • 6屠世忠.黄酮类化合物的生物活性[J].国外医学:药学分册,1979,4:200-200.
  • 7刘崇铭 于庆海 等.淫羊藿苷对心脏的影响[J].中草药,1982,13(9):31-31.
  • 8Hidalg I J, Raub T J, Borchadt R T. Characterization of the human colon carcinoma, cell line (Caco-2) as a model system for intestinal epithelial permeability [J]. Gasteoenterology, 1989,96:736.
  • 9Hu M, Chen J, Tran D, et al. The Caco-2 cell monolayers as an intestinal metabolism model: metabolism of dipeptide Phe-Pro [J]. Drug Target, 1994,2 : 79.
  • 10Hu M, Chen J, Zhu Y, et al. Mechanism and kinetics of transcellular transport of a new β-actam antibiotic loracarbef across an human intestinal epithelial model system (Caeo-2) [J]. Pharm Res, 1994,11: 1405.

共引文献75

同被引文献223

引证文献14

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部